Nathalie Moll joined the European Federation of Pharmaceutical Industries and Associations (EFPIA) as Director General in April 2017.
EFPIA represents the pharmaceutical industry operating in Europe. Together with its direct membership 40 leading pharmaceutical companies, 33 national associations representing over 1,900 companies and in collaboration with health and research players, EFPIA's mission is to create an environment that enables our members to innovate, discover, develop and deliver new therapies and vaccines for people across Europe, as well as contribute to the European economy.
Prior to joining EFPIA, between 2010 and 2017 Nathalie was the Secretary General of EuropaBio ranked as the most effective European Trade Association in Brussels in 2013. She spent over 20 years working for the biotech industry at EU and national level in associations and corporate positions and held the position of Chair and Vice Chair of the International Council of Biotech Associations (ICBA).
In 2013, Nathalie won the Technovisionaries Women Innovation Award organised by Women & Technologies® while in 2009, Nathalie and the Green Biotech Team of EuropaBio were presented with the Leadership and Excellence in Advancing Ag-Biotech and Food Issues Award. Nathalie was also named one of the 15 leading women in biotech in Europe in 2017.
Nathalie holds an Honours Degree in Biochemistry and Biotechnology from St Andrews University, Scotland.
The World Health Organization (WHO) declared Covid-19 outbreak a public health emergency of international concern on 30 January, the highest level of alarm under international law.The virus has tested our health systems and societies to their core, highlighting the weaknesses and ability of the countries to handle a large-scale public health crisis. The pandemic has grown to constitute the largest global public health crisis in a century with formidable health, social and economic challenges across the world. WHO Director-General Tedros Adhanom Ghebreyesus has stressed that “The global coronavirus outbreak is the sort of disaster whose effects will last far into the future”. What are the lessons learnt from the pandemic so far? What can be done better in the future to contain large scale effects of global pandemic? How can we rebuild trust in multilateral institutions and encourage more profound international cooperation to handle health emergencies? How can we re-wire and improve our global health institutions?